 Prolonged treatment children chronic hepatitis recombinant alpha study prospective study efficacy tolerance alpha-interferon children biopsy-proven HBsAg/HBeAg/HBV-DNA-positive anti-delta-negative chronic hepatitis Patients alpha INF MU im times months treatment patients group patients IFN marked decrease negativization HBV-DNA treatment end study month patients HBV-DNA HBeAb months disappearance HBV-DNA normalization aminotransferase values control group patient spontaneous clearance HBV-DNA conversion HBeAb normalization aminotransferase levels patients febrile reaction first month treatment dose IFN patients persistent intolerance Patients decreased viral replication initial biochemical histological activity nonresponders data suggest IFN treatment progression chronic hepatitis children history acute hepatitis active chronic disease